OMNIPAQUE 300mg I/ml 300mg I / ml injectible solution medication leaflet

V08AB02 iohexol • Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media

Iohexol is a contrast agent used in medical imaging, including computed tomography (CT) and angiography. It helps visualize internal structures by enhancing the contrast between different tissues.

The medication is administered intravenously or intrathecally, as directed by a doctor. It is important to monitor the patient for adverse reactions during the procedure.

Side effects may include nausea, vomiting, a sensation of warmth, or allergic reactions. In rare cases, severe reactions such as anaphylactic shock or renal failure may occur.

Iohexol is not recommended for patients with hypersensitivity to iodinated contrast agents or severe renal impairment.

General data about OMNIPAQUE 300mg I/ml 300mg I / ml

Substance: iohexol

Date of last drug list: 01-06-2025

Commercial code: W07804012

Concentration: 300mg I / ml

Pharmaceutical form: injectible solution

Packing volume: 100 ml

Product type: original

Price: 877.77 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GE HEALTHCARE IRELAND LTD. - IRLANDA

Holder: GE HEALTHCARE AS - NORVEGIA

Number: 11404/2019/07

Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-it is used immediately

Concentrations available for iohexol

240mg I /ml, 300mg I /ml, 350mg I /ml